Literature DB >> 18948685

Osteoporosis: an age-related and gender-specific disease--a mini-review.

Peter Pietschmann1, Martina Rauner, Wolfgang Sipos, Katharina Kerschan-Schindl.   

Abstract

Osteoporosis, a classical age-related disease and known to be more common in women than in men, has been reported increasingly often in men during the past few years. Although men at all ages after puberty have larger bones than women, resulting in greater bending strength, mortality after a hip fracture, one of the major complications of osteoporosis, is more common in men than in women. Sex hormone deficiency is associated with unrestrained osteoclast activity and bone loss. Even though estrogen deficiency is more pronounced in women, it appears to be a major factor in the pathogenesis of osteoporosis in both genders. In contrast to osteoporosis in postmenopausal women, the treatment of osteoporosis in men has been scarcely reported. Nevertheless, some drugs commonly used for the treatment of osteoporosis in women also appear to be effective in men. The aim of this study is to review primary osteoporosis in the elderly with particular emphasis on gender-related aspects. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18948685     DOI: 10.1159/000166209

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  77 in total

Review 1.  Bone health and type 2 diabetes mellitus: a systematic review.

Authors:  Erin Gorman; Anna M Chudyk; Kenneth M Madden; Maureen C Ashe
Journal:  Physiother Can       Date:  2011-01-20       Impact factor: 1.037

2.  Modeling perimenopause in Sprague-Dawley rats by chemical manipulation of the transition to ovarian failure.

Authors:  Jennifer B Frye; Ashley L Lukefahr; Laura E Wright; Sam L Marion; Patricia B Hoyer; Janet L Funk
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

Review 3.  HDL cholesterol and bone mineral density: is there a genetic link?

Authors:  Cheryl L Ackert-Bicknell
Journal:  Bone       Date:  2012-02       Impact factor: 4.398

4.  Diagnosis of contact injuries in a mediaeval skeleton analysed by µCT and histology.

Authors:  Doris Schamall; Peter Pietschmann; Doris Moser; Martin Dockner; Maria Teschler-Nicola
Journal:  Wien Med Wochenschr       Date:  2012-09-20

Review 5.  Functional impairment of bone formation in the pathogenesis of osteoporosis: the bone marrow regenerative competence.

Authors:  Joseph P Bidwell; Marta B Alvarez; Mark Hood; Paul Childress
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

6.  Using Anisotropic 3D Minkowski Functionals for Trabecular Bone Characterization and Biomechanical Strength Prediction in Proximal Femur Specimens.

Authors:  Mahesh B Nagarajan; Titas De; Eva-Maria Lochmüller; Felix Eckstein; Axel Wismüller
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-04-09

7.  MiR-351 negatively regulates osteoblast differentiation of MSCs induced by (+)-cholesten-3-one through targeting VDR.

Authors:  Qiuke Hou; Yongquan Huang; Yiwen Luo; Bin Wang; Yamei Liu; Rudong Deng; Saixia Zhang; Fengbin Liu; Dongfeng Chen
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Modeling transcranial electrical stimulation in the aging brain.

Authors:  Aprinda Indahlastari; Alejandro Albizu; Andrew O'Shea; Megan A Forbes; Nicole R Nissim; Jessica N Kraft; Nicole D Evangelista; Hanna K Hausman; Adam J Woods
Journal:  Brain Stimul       Date:  2020-02-06       Impact factor: 8.955

9.  Central and peripheral fat body mass have a protective effect on osteopenia or osteoporosis in adults and elderly?

Authors:  P M S S Freitas; M L Garcia Rosa; A M Gomes; V Wahrlich; D G Di Luca; R A da Cruz Filho; D M da Silva Correia; C A Faria; E M Yokoo
Journal:  Osteoporos Int       Date:  2015-12-09       Impact factor: 4.507

10.  Tenofovir-associated bone density loss.

Authors:  Iwen F Grigsby; Lan Pham; Louis M Mansky; Raj Gopalakrishnan; Kim C Mansky
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.